Nuvation Bio Stock Analysis
| NUVB Stock | USD 1.98 0.02 1.02% |
Nuvation Bio is overvalued with Real Value of 1.9 and Hype Value of 1.98. The main objective of Nuvation Bio stock analysis is to determine its intrinsic value, which is an estimate of what Nuvation Bio is worth, separate from its market price. There are two main types of Nuvation Bio's stock analysis: fundamental analysis and technical analysis.
The Nuvation Bio stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Nuvation Bio's ongoing operational relationships across important fundamental and technical indicators.
Nuvation |
Nuvation Stock Analysis Notes
About 27.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.45. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nuvation Bio recorded a loss per share of 2.11. The entity had not issued any dividends in recent years. Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York. Nuvation Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 85 people. To find out more about Nuvation Bio contact David Hung at 332 208 6102 or learn more at https://www.nuvationbio.com.Nuvation Bio Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nuvation Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nuvation Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Nuvation Bio generated a negative expected return over the last 90 days | |
| Nuvation Bio has high historical volatility and very poor performance | |
| Nuvation Bio may become a speculative penny stock | |
| The company reported the previous year's revenue of 7.87 M. Net Loss for the year was (567.94 M) with profit before overhead, payroll, taxes, and interest of 795 K. | |
| Nuvation Bio currently holds about 703.8 M in cash with (130.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 59.0% of the company shares are owned by institutional investors |
Nuvation Bio Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nuvation Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Nuvation Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 670.58 M.Technical Drivers
As of the 21st of March, Nuvation Bio secures the Standard Deviation of 5.09, risk adjusted performance of (0.06), and Mean Deviation of 3.29. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nuvation Bio, as well as the relationship between them.Nuvation Bio Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nuvation Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nuvation Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Nuvation Bio Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nuvation Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nuvation Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nuvation Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nuvation Bio Outstanding Bonds
Nuvation Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nuvation Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nuvation bonds can be classified according to their maturity, which is the date when Nuvation Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| US67080LAA35 Corp BondUS67080LAA35 | View |
Nuvation Bio Predictive Daily Indicators
Nuvation Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nuvation Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Nuvation Bio Forecast Models
Nuvation Bio's time-series forecasting models are one of many Nuvation Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nuvation Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Nuvation Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Nuvation Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nuvation shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nuvation Bio. By using and applying Nuvation Stock analysis, traders can create a robust methodology for identifying Nuvation entry and exit points for their positions.
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York. Nuvation Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 85 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Nuvation Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Complementary Tools for Nuvation Stock analysis
When running Nuvation Bio's price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |